aTyr Pharma | LIFE - Ebit

Stock Price
0.50
Daily Change
-0.06 -9.98%
Monthly
-39.31%
Yearly
-84.59%
Q2 Forecast
0.49

aTyr Pharma reported $24.47M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Ardelyx USD 5.1M 2.02M Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
Biogen USD 514.3M 502.8M Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD 56.04M 63.94M Dec/2025
CSL USD 2.64B 116M Dec/2025
Curis USD -7.88M 4.31M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Grifols EUR 320.55M 91.01M Dec/2025
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Novartis USD 4.18B 118M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
United Therapeutics USD 325.8M 340.4M Mar/2026
Xoma USD -10.08M 4.4M Jun/2024